(1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid, 95.0%, 5g

Ammonium cerium (IV) nitrate, 99.0%, 25g

5-Chloropyridazin-4-ol, 95.0%, 250mg

4-Iodo-2,2-dimethyltetrahydro-2H-pyran, 97%, 5g

(2E)-3-(3-nitrophenyl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

Hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate, 98%, 1kg

2-(5-Bromothiophen-2-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, 95+%, 200mg

1-[(benzyloxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid, 95.0%, 500mg

2-((6-Chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, 98.00%, 10g

3-Iodo-N-methylpyridin-4-amine, 97.0%, 250mg

2-(5-Bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

N-(2-(cyclohex-1-en-1-yl)ethyl)-2-(4-methoxyphenyl)acetamide, 97%, 250mg